The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer
- PMID: 15367420
- DOI: 10.1093/annonc/mdh396
The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer
Comment on
-
Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial.Ann Oncol. 2004 May;15(5):743-50. doi: 10.1093/annonc/mdh173. Ann Oncol. 2004. PMID: 15111341 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
